The anti-NASH effect of IMA-1 mainly depends on its direct binding to the ALOX12 pocket near the interactive surface of ACC1, rather than inhibit the activity of ALOX12 lipoxygenase. The gene discussed is TMEM201; the disease is metabolic dysfunction-associated steatohepatitis.